AKBA vs CAG · rev $102.7M vs P/E 31, rev $11.28B
Akebia Ther (AKBA) versus ConAgra Foods Inc (CAG) — a side-by-side from cached financials, not a winner call.
Akebia Ther (AKBA) is a drug manufacturers - specialty & generic company listed on US.
ConAgra Foods Inc (CAG) is a packaged foods company listed on US.
Latest reported AKBA revenue for 2026-06-30 was $102.7M. Net income was -$18.0M. Revenue was up 91.8% from 2026-03-31 to 2026-06-30. AKBA currently screens at market cap $260.1M.
Latest reported CAG revenue for 2026-05-31 was $11.28B. Net income was -$1.92B. Revenue was down 2.9% from 2025-05-25 to 2026-05-31. CAG currently screens at market cap $10.02B and trailing P/E 30.9.
AKBA currently screens at market cap $260.1M. CAG currently screens at market cap $10.02B and trailing P/E 30.9.
Not investment advice. Open the AKBA and CAG stock pages for the full models.
Not investment advice.